Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004528 |
ID: | TCMBANKHE004528 |
植物拉丁名: |
|
功能与主治: | See Glycyrrhiza uralensis ./See Glycyrrhiza uralensis. |
药用植物名: | 黄甘草 |
药用部位: | root and rhizome |
TCM_ID_id: | 1460 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN004087 | glyoxal | ZINC8437750; DSSTox_CID_5364; 40094-65-3; SC-19118; MCULE-3212938778; MolPort-001-780-154; Diformyl; F2191-0152; STL146635; NSC-262684; Biformyl; BRN 1732463; RP18241; Glyoxal aldehyde; Glyoxal, 40%; ANW-43524; Ethane-1,2-dione; 57421-EP2308878A2; BB_SC-7204; 57421-EP2269977A2; 57421-EP2270006A1; 4-01-00-03625 (Beilstein Handbook Reference); oxaldehyde; CAS-107-22-2; Ethanedial; Glyoxal solution, 40 wt. % in H2O; 50NP6JJ975; Glyoxylaldehyde; Biformal; FT-0626792; KB-52297; 107-22-2; Glyoxal, 40% in water; J-001740; EC 203-474-9; Oxypolygelatin; NCGC00091228-01; X8004; (CHO)2; NSC 262684; (oxo)acetaldehyde; Protectol GL 40; Aerotex glyoxal 40; AC1Q28J9; Ethanedial, trimer; EINECS 203-474-9; RTR-001406; Glyoxal solution, BioReagent, for molecular biology, ~40% in H2O (~8.8 M); UNII-50NP6JJ975; Glyoxal, 40 % Solution; Glyoxal, 40% w/w aq. soln.; Glycoxal; ODIX; oxypolygelatine; KS-00000V42; MFCD00006957; Glyoxal solution; Gelatins, reaction products with glyoxal, oxidized; ethane dial; Glyoxal solution, 40.0%; Glyfosfin; GLYOXAL; CHEMBL1606435; DTXSID5025364; Tox21_111105; C14448; Glyoxal solution, 40 wt. % in water 100ml; LS-436; 57421-EP2289896A1; Glyoxal solution, CP, 40 wt. % in H2O; Glyoxal, 29.2%; DSSTox_RID_77764; 83513-30-8; AC1L1PPU; NSC262684; 1,2-Ethanedione; oxalic acid dihydride; Tox21_202517; Gelifundol; GLYOXAL, 76%, POWDER (TRIMER); Glyoxal, Biformyl, Oxalaldehyde; Oxalaldehyde; AI3-24108; Glyoxal solutions; Glyoxal solution, ~40% in H2O, for HPLC derivatization; DSSTox_GSID_25364; ACMC-1BV6U; CHEBI:34779; BIDD:ER0284; ethane-1,2-dial; NCGC00260066-01; AN-22473; Glyoxal solution, ~40% in H2O (~8.8 M); LEQAOMBKQFMDFZ-UHFFFAOYSA-N; BBL011519; 57421-EP2377845A1; Diformal; HSDB 497; TR-001406; TRA0067179; S14-1487; C2H2O2; Ethandial; AKOS000119169; Ethanediol, trimer; CTK0H4953; Ethanedione; CCRIS 952; 9005-91-8; G0152 | C2H2O2 | 58.04 g/mol | C(=O)C=O |
| TCMBANKIN010856 | uralsaponin a | C42H62O16 | 822.9 g/mol | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C | |
| TCMBANKIN013366 | glyeurysaponin | C42H62O16 | 822.9 g/mol | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C | |
| TCMBANKIN016653 | formononetin-7-glucoside | C22H22O9 | 430.4 g/mol | COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3)OC4C(C(C(C(O4)CO)O)O)O | |
| TCMBANKIN016878 | vicianin | Benzeneacetonitrile, alpha-((6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranosyl)oxy)-, (R)-; (2R)-2-phenyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile; Vicianin; CQU61CXY3D; AC1O533C; UNII-CQU61CXY3D | C19H25NO10 | 427.4 g/mol | C1C(C(C(C(O1)OCC2C(C(C(C(O2)OC(C#N)C3=CC=CC=C3)O)O)O)O)O)O |
| TCMBANKIN020048 | glycyroside | Glycyroside; LMPK12050024; Formononetin 7-O-apiosyl-(1->2)-glucoside | C27H30O13 | 562.52 | COC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)OC4C(C(C(C(O4)CO)O)O)OC5C(C(CO5)(CO)O)O |
| TCMBANKIN028121 | glandulone c | C15H20O3 | 248.32 g/mol | CC1=CC(C(=CC1=O)C(C)CCC=C(C)C=O)O | |
| TCMBANKIN030693 | liquoric acid | liquoricacid | C30H44O5 | 484.7 g/mol | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CC5C6(C4CC(C(C6)O5)(C)C(=O)O)C)C)C)C |
| TCMBANKIN033218 | Eurycarpin A | eurycarpin a; 3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-7-hydroxy-chromen-4-one; 3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-7-hydroxychromen-4-one; 3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-7-hydroxy-chromone; 3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-7-hydroxy-4-chromenone | C20H18O5 | 338.4 g/mol | CC(=CCC1=C(C=CC(=C1O)C2=COC3=C(C2=O)C=CC(=C3)O)O)C |
| TCMBANKIN034139 | uralsaponin B | uralsaponin b | C42H62O16 | 822.93 | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C |
| TCMBANKIN036866 | glycyrrhizic acid | glycyrrhizicacid; CS-W019908; Glycyrrhizic acid | C42H62O16 | 822.93 | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C |
| TCMBANKIN036867 | glycyrrhetinic acid | beta-Glycyrrhetic acid; glycyrrhetinicacid; 3-hydroxy-11-oxoolean-12-en-29-oate; (2S,4aS,6aS,6bR,10S,12aS)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; LT00233150; Glycyrrhetic acid; Glycyrrhetinic; 3b-hydroxy-11-oxo-Olean-12-en-30-oic acid; 3-hydroxy-11-oxoolean-12-en-29-oic acid (ACD/Name 4.0); 18b-Glycyrrhetic acid; Glycyrrhetin; Glycyrrhetinate; 3b-Hydroxy-11-oxoolean-12-en-30-oic acid; 18b-Glycyrrhtinic acid; Biosone; 3b-Hydroxy-11-oxoolean-12-en-30-oate; 3-Glycyrrhetinic acid; SCHEMBL13144257; 18b-Glycyrrhetinic acid; NCGC00186652-01; 3b-hydroxy-11-oxo-Olean-12-en-30-oate; b-glycyrrhetic acid; (2S,4AS,6AS,6BR,10S,12AS)-10-HYDROXY-2,4A,6A,6B,9,9,12A-HEPTAMETHYL-13-OXO-3,4,5,6,7,8,8A,10,11,12,12B,14B-DODECAHYDRO-1H-PICENE-2-CARBOXYLIC ACID; a-glycyrrhetinic acid | C30H46O4 | 470.68 | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C |
| TCMBANKIN037368 | glycyrrhetic acid acetate | C32H48O5 | 512.7 g/mol | CC(=O)OC1CCC2(C(C1(C)C)CCC3(C2C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C | |
| TCMBANKIN038275 | (+)-medioresinol | (+)-Medioresinol di-O-beta-D-glucopyranoside_qt | C21H24O7 | 388.41 | COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C=C4)O)OC |
| TCMBANKIN038308 | isoliquiritin | MolPort-001-742-630; 7014-39-3; 5041-81-6; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(4-(beta-D-glucopyranosyloxy)phenyl)-, (2E)-; C16978; Q-100563; BDBM50362885; (E)-1-(2,4-dihydroxyphenyl)-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl]prop-2-en-1-one; SCHEMBL676338; 4-beta-D-glucopyranosyloxy-2',4'-dihydroxy-trans-chalcone; I07-0258; Isoliquiritin; X1193; 2Y348H1V4W; MEGxp0_001945; YNWXJFQOCHMPCK-LXGDFETPSA-N; CHEMBL599763; UNII-2Y348H1V4W; AKOS015897131; X1167; AC1NSX26; BG01706425; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-[4-(.beta.-D-glucopyranosyloxy)phenyl]-, (2E)-; AK554321; AT-28971; 4-[(1E)-3-(2,4-dihydroxyphenyl)-3-oxoprop-1-en-1-yl]phenyl beta-D-glucopyranoside; N1750; (E)-1-(2,4-dihydroxyphenyl)-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-en-1-one; MFCD00272145; ZINC33832004; LMPK12120021; 4-(beta-D-Glucopyranosyloxy)-2',4'-dihydroxychalcone; AK544982; CHEBI:80839; Neoisoliquritin | C21H22O9 | 418.394 | c1([H])c(O[H])c(C(=O)\C([H])=C([H])\c2c([H])c([H])c(O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])c([H])c2[H])c([H])c([H])c1O[H] |
| TCMBANKIN039049 | Isoviolanthin | 7,4'-Dihydroxyflavone; isoviolanthin | 254.24 | ||
| TCMBANKIN040788 | liquiritin | (2S)-7-hydroxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxyphenyl]chroman-4-one; CTK8G0592; 7-hydroxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydrochromen-4-one; MCULE-9356107980; 4H-1-Benzopyran-4-one, 2-(4-(beta-D-glucopyranosyloxy)phenyl)-2,3-dihydro-7-hydroxy-, (S)-; 7-Hydroxyflavanone 4'-O-glucoside; (2S)-7-hydroxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl]chroman-4-one; (2S)-7-hydroxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chroman-4-one; MLS000575018; AIDS166098; 4',7-Dihydroxyflavanone 4'-(beta-D-glucopyranoside); 551-15-5; SMR000232362; AIDS-166098; Likviritin; 4',7-Dihydroxyflavanone 4'-(beta-D-glucoside); 100483-53-2; MolPort-021-804-452; 17654-21-6; Liquiritoside; 30372-08-8; (S)-7-Hydroxy-2-[4-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-phenyl]-chroman-4-one; 31564-20-2; (2S)-7-hydroxy-2-[4-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]phenyl]-4-chromanone; (S)-2-(4-(beta-D-Glucopyranosyloxy)phenyl)-2,3-dihydro-7-hydroxy-4H-1-benzopyran-4-one; LMPK12140021 | C21H22O9 | 418.394 | c1([H])c([H])c(C(=O)C([H])([H])[C@]([H])(c2c([H])c([H])c(O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])c([H])c2[H])O4)c4c([H])c1O[H] |
| TCMBANKIN040896 | Violanthin | 578.52 | |||
| TCMBANKIN041280 | Licochalcone B | licochalcone b; AIDS095932; 3-(3,4-dihydroxy-2-methoxy-phenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one; 58749-23-8; (E)-3-(3,4-dihydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one; (E)-3-(3,4-Dihydroxy-2-methoxy-phenyl)-1-(4-hydroxy-phenyl)propenone; (E)-3-(3,4-dihydroxy-2-methoxy-phenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one; (E)-3-(3,4-Dihydroxy-2-methoxy-phenyl)-1-(4-hydroxy-phenyl)-propenone; 3-(3,4-dihydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one; AIDS-095932 | 286.279 | ||
| TCMBANKIN042133 | Kanzonol B | 322.4 g/mol | |||
| TCMBANKIN042957 | Sophoraflavone B | LMPK12110025; Sophoraflavone B | 416.4 g/mol | ||
| TCMBANKIN044756 | 6,8-bis(c-glucosyl)-apigenin | C27H30O15 | C1=CC(=CC=C1C2=C(C(=O)C3=C(C(=C(C=C3O2)O)C4C(C(C(C(O4)CO)O)O)O)O)C5C(C(C(C(O5)CO)O)O)O)O | ||
| TCMBANKIN048791 | licochalcone A | AIDS-060352; D08GEN; LMPK12120424; 749L227; AN-276; (E)-3-[5-(1,1-Dimethyl-allyl)-4-hydroxy-2-methoxy-phenyl]-1-(4-hydroxy-phenyl)-propenone; (2E)-3-[4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; (E)-3-[5-(1,1-dimethylallyl)-4-hydroxy-2-methoxy-phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; Licochalcone-A, Synthetic; LICOAGROCHACONE A; SCHEMBL114042; HY-N0372; licochalcone a; CS-5603; 4 inverted exclamation marka,4-Dihydroxy-3-; EX-A1193; BRD-K99667445-001-01-4; 2-Propen-1-one, 3-[5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hydroxyphenyl)- (E)-; Licohalconel A; AIDS060352; 3-[5-((E)-1,1-Dimethyl-allyl)-4-hydroxy-2-methoxy-phenyl]-1-(4-hydroxy-phenyl)-propenone; (E)-3-(4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one; 3-[5-(1,1-dimethylprop-2-enyl)-4-hydroxy-2-methoxy-phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; (E)-3-[4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; (2E)-3-[5-(1,1-dimethylprop-2-en-1-yl)-4-hydroxy-2-methoxyphenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; NP-012615; Q-100677; AK198741; 3-[4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; 3-[5-(1,1-dimethylprop-2-enyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; C21H22O4; 3-Dimethylallyl-4,4'-dihydroxy-6-methoxychalcone; s7828; KAZSKMJFUPEHHW-DHZHZOJOSA-N; (E)-3-[5-(1,1-dimethylprop-2-enyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; BDBM50068270; LS-122598; HSCI1_000078; MolPort-005-945-554; JTV5467968; ZINC3873123; Licochalcone-A; MolPort-044-567-637; (E)-3-[5-(1,1-dimethylprop-2-enyl)-4-hydroxy-2-methoxy-phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; V2343; Licochalcone A; 58749-22-7; CCG-208030; Licochalcone A, >=96.0% (HPLC); AB0021119; EBD46703; CHEMBL139702; CHEBI:125689; UNII-JTV5467968; AC1NSXJH; AKOS026673964; A-dimethylallyl-6-methoxychalcone; 2-Propen-1-one, 3-(5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)-, (E)-; (E)-3-[5-(1,1-Dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hydroxyphenyl)-2-propen-1-one; BG01626652 | C21H22O4 | 338.397 | c1(O[H])c([H])c([H])c(C(=O)\C([H])=C([H])/c2c([H])c(C(C([H])=C([H])[H])(C([H])([H])[H])C([H])([H])[H])c(O[H])c([H])c2OC([H])([H])[H])c([H])c1[H] |
| TCMBANKIN049471 | glabrol | C25H28O4 | 392.487 | [C@]1([H])(c2c([H])c([H])c(O[H])c(C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])c2[H])Oc(c(C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])c(O[H])c([H])c3[H])c3C(=O)C1([H])[H] | |
| TCMBANKIN057918 | urea | 1-Benzhydryl-3-[4-(methoxy-quinolin-8-ylamino)-pentyl]-urea; 1-(3-benzylphenyl)-3-[4-[(3-methoxy-1-naphthyl)amino]pentyl]urea; UR; Mocovina [Czech]; 51457_FLUKA; Aquacare HP; Keratinamin Kowa; KBio2_003720; 51456_FLUKA; NCGC00090892-03; NCI-C02119; 174693-33-5; 51460_FLUKA; EPA Pesticide Chemical Code 085702; KBioGR_001775; 173994-65-5; Carbaderm; 173144-80-4; Alphadrate; AIDS-003652; NSC 34375; KBio1_000086; Pastaron; HSDB 163; U7129_SIGMA; Carbamimic acid; Carbonyldiamine; c0165; 299367_ALDRICH; SPBio_001263; Ureaphil; Karbamid; NCGC00090892-01; Urea ammonium nitrate solution; Pastaron soft; Carmol 40; B-I-K; Urevert; Urea-13C; Panafil; U6504_SIGMA; 51465_FLUKA; 57-13-6; Keratinamin; Spectrum4_001168; Elaqua XX; H2NC(O)NH2; U1250_SIGMA; KBio2_001152; Urepeal L; KBio3_002843; ST5214565; URE; BSPBio_003341; D00023; Urea [JAN]; AI3-01202; NCGC00090892-02; Benural 70; WLN: ZVZ; DivK1c_000086; Pastaron (TN); carmol; Urea perhydrate; Polyurea; Hyanit; NINDS_000086; Eucerin 10% Urea Lotion; InChI=1/CH4N2O/c2-1(3)4/h(H4,2,3,4; Carbamimidic acid (VAN); U4128_SIGMA; Caswell No. 902; Spectrum_000672; Pastaron 20; U4883_SIGMA; CCRIS 989; 37955-36-5; Urea (8CI,9CI); U5128_SIAL; Varioform II; Pastaron 10; U0631_SIGMA; Harnstoff; Carbamide resin; Aqua Care; ARF; CHEBI:16199; Ureophil; Pseudourea; Ureacin-40 Creme; AIDS003652; C00086; KBioSS_001152; Optigen 1200; Spectrum5_001862; SPECTRUM1500604; Carbamimidic acid; 175276-38-7; U5378_SIGMA; carbamide; Spectrum2_001192; EINECS 200-315-5; Supercel 3000; Ureacin-10 lotion; IDI1_000086; component of Artra Ashy Skin Cream; Isourea; U4884_SIGMA; Urea solution; Aquacare; UREA; KBio2_006288; Rubinol ST 010; 51459_FLUKA; NSC34375; Aqua Care HP; Spectrum3_001791; Ultra Mide; Urepearl; uree; Prespersion, 75 urea; Urea-12C; Urea (JP15/USP); Carbonyldiamide; Harnstoff [German]; 4744-36-9; Aquadrate; Urea, homopolymer; 30535-50-3; Pastaron 20 soft; Urepeal; Carbonyl diamide; 33247_RIEDEL; Ureacin-20 | CH4N2O | 60.056 g/mol; 60.06 | C(=O)(N)N |
| TCMBANKIN058249 | phloretinicacid | p-hydroxyphenyl-propionic acid; p-hydroxy-phenylpropionic acid;p-hydroxyphenylpropionic acid | C9H10O3 | 166.17 g/mol | C1=CC(=CC=C1CCC(=O)O)O |
| TCMBANKIN058479 | vicianin | Benzeneacetonitrile, alpha-((6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranosyl)oxy)-, (R)-; (2R)-2-phenyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile; Vicianin; CQU61CXY3D; AC1O533C; UNII-CQU61CXY3D; lupulinoside | C19H25NO10 | 427.4 g/mol | C1C(C(C(C(O1)OCC2C(C(C(C(O2)OC(C#N)C3=CC=CC=C3)O)O)O)O)O)O |
| TCMBANKIN058585 | norlobelanine | isolobelanine | C21H23NO2 | 321.4 g/mol | C1CC(NC(C1)CC(=O)C2=CC=CC=C2)CC(=O)C3=CC=CC=C3 |
| TCMBANKIN059489 | Glabrone | C20H16O5 | 336.34g/mol | CC1(C=CC2=C(O1)C=CC(=C2O)C3=COC4=C(C3=O)C=CC(=C4)O)C | |
| TCMBANKIN060529 | Tormentic acid | C30H48O5 | 488.7 g/mol | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1(C)O)C)C(=O)O | |
| TCMBANKIN060691 | poriferast-5-en-3beta-ol;22,23-dihydrostigmasterol;gamma-sitosterol;clionasterol;beta-dihydrofucosterol | C29H50O | 414.71 g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN061765 | medioresinol | 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenol; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxyphenol; (–)-Medioresinol; (+)-medioresinol; (+)-Medioresinol di-O-beta-D-glucopyranoside_qt; 40957-99-1 | C21H24O7 | 388.4 g/mol | COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C=C4)O)OC |
| TCMBANKIN061887 | medicarpin-3-o-glucoside | (2S,3R,4S,5S,6R)-2-[[(6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-benzofurano[3,2-c]chromen-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; Medicarpin 3-O-glucoside; C16223; (2S,3R,4S,5S,6R)-2-[[(6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-benzofurano[3,2-c]chromen-3-yl]oxy]-6-methylol-tetrahydropyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[[(6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-[1]benzoxolo[3,2-c]chromen-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol | C22H24O9 | 432.4 g/mol | COC1=CC2=C(C=C1)C3COC4=C(C3O2)C=CC(=C4)OC5C(C(C(C(O5)CO)O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab